Total Payments
$15,263
2024 Payments
$1,899
Companies
44
Transactions
490
Medicare Patients
10,679
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$10,783 (70.7%)
Consulting$3,696 (24.2%)
Education$585.18 (3.8%)
Travel$198.28 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,783 | 477 | 70.7% |
| Consulting Fee | $3,696 | 1 | 24.2% |
| Education | $585.18 | 10 | 3.8% |
| Travel and Lodging | $198.28 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $4,261 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,764 | 67 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,447 | 83 | $0 (2024) |
| ABBVIE INC. | $909.69 | 42 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $805.32 | 40 | $0 (2024) |
| Janssen Biotech, Inc. | $662.33 | 33 | $0 (2024) |
| Lilly USA, LLC | $622.45 | 32 | $0 (2024) |
| PFIZER INC. | $550.87 | 27 | $0 (2024) |
| Organogenesis Inc. | $452.88 | 11 | $0 (2023) |
| MAYNE PHARMA INC. | $345.17 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,899 | 84 | E.R. Squibb & Sons, L.L.C. ($461.23) |
| 2023 | $1,701 | 81 | E.R. Squibb & Sons, L.L.C. ($217.27) |
| 2022 | $1,319 | 58 | Regeneron Healthcare Solutions, Inc. ($248.68) |
| 2021 | $1,506 | 53 | ORGANOGENESIS INC. ($291.76) |
| 2020 | $774.09 | 34 | Regeneron Healthcare Solutions, Inc. ($309.40) |
| 2019 | $5,682 | 62 | GENZYME CORPORATION ($3,988) |
| 2018 | $1,621 | 78 | Regeneron Healthcare Solutions, Inc. ($255.63) |
| 2017 | $761.14 | 40 | PFIZER INC. ($168.26) |
All Payment Transactions
490 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.67 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $21.37 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $100.04 | General |
| 11/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.10 | General |
| Category: Immunology | ||||||
| 11/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.37 | General |
| Category: Immunology | ||||||
| 11/06/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.29 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.09 | General |
| Category: Immunology | ||||||
| 10/31/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: DERMATOLOGY | ||||||
| 10/28/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: ANTIBIOTIC | ||||||
| 10/16/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: Immunology | ||||||
| 10/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.98 | General |
| Category: Immunology | ||||||
| 10/02/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: DERMATOLOGY | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Dermatology | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.31 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 4,153 | 14,947 | $1.5M | $511,013 |
| 2022 | 42 | 3,372 | 13,698 | $1.2M | $408,090 |
| 2021 | 38 | 2,264 | 11,030 | $902,758 | $324,593 |
| 2020 | 19 | 890 | 1,361 | $664,405 | $265,404 |
Total Patients
10,679
Total Services
41,036
Medicare Billing
$1.5M
Procedure Codes
143
All Medicare Procedures & Services
143 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 144 | 191 | $255,669 | $91,937 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 412 | 676 | $121,270 | $42,701 | 35.2% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 77 | 119 | $96,474 | $37,864 | 39.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 548 | 1,399 | $100,912 | $37,556 | 37.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 374 | 533 | $106,181 | $31,395 | 29.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 285 | 390 | $86,614 | $31,296 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 245 | 324 | $82,241 | $29,331 | 35.7% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 70 | 85 | $71,740 | $20,628 | 28.8% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 82 | 92 | $86,420 | $18,620 | 21.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 323 | 549 | $72,692 | $17,414 | 24.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 193 | 415 | $41,462 | $16,112 | 38.9% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 32 | 36 | $45,235 | $16,031 | 35.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 126 | 126 | $41,956 | $15,004 | 35.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 134 | 134 | $30,170 | $10,343 | 34.3% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 18 | 6,800 | $22,478 | $8,811 | 39.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 235 | 1,615 | $20,813 | $8,068 | 38.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 141 | 185 | $20,767 | $7,554 | 36.4% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 18 | 33 | $17,891 | $6,841 | 38.2% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 21 | 23 | $18,145 | $6,634 | 36.6% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 17 | 20 | $15,479 | $6,083 | 39.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 40 | 46 | $15,361 | $5,846 | 38.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 34 | 36 | $12,739 | $4,337 | 34.0% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 24 | 27 | $11,038 | $3,949 | 35.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 30 | 35 | $16,957 | $3,331 | 19.6% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 21 | 25 | $9,574 | $3,153 | 32.9% |
About Dr. Michael Wangia, MD
Dr. Michael Wangia, MD is a MOHS-Micrographic Surgery healthcare provider based in Winter Garden, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2009. The National Provider Identifier (NPI) number assigned to this provider is 1548495955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Wangia, MD has received a total of $15,263 in payments from pharmaceutical and medical device companies, with $1,899 received in 2024. These payments were reported across 490 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($10,783).
As a Medicare-enrolled provider, Wangia has provided services to 10,679 Medicare beneficiaries, totaling 41,036 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 143 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Winter Garden, FL
- Active Since 05/29/2009
- Last Updated 09/28/2020
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1548495955
Products in Payments
- LIBTAYO (Drug) $3,894
- DUPIXENT (Biological) $1,549
- COSENTYX (Biological) $1,172
- Sotyktu (Drug) $786.37
- EUCRISA (Drug) $503.72
- TALTZ (Drug) $481.42
- Otezla (Drug) $474.66
- Humira (Biological) $438.02
- TREMFYA (Drug) $321.32
- DUPIXENT DUPILUMAB INJECTION (Biological) $302.40
- SKYRIZI (Biological) $292.84
- Puraply (Medical Supply) $275.75
- DORYX (Drug) $265.62
- Tremfya (Drug) $241.67
- Erivedge (Biological) $218.67
- COSENTYX (Drug) $187.95
- Puraply Antimicrobial (Medical Supply) $177.13
- DUPIXENT (Drug) $176.46
- AMELUZ (Drug) $173.84
- VTAMA (Drug) $140.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.